BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6191128)

  • 1. Changes in dihydrotestosterone metabolism and the development of benign prostatic hyperplasia in the aging beagle.
    Isaacs JT
    J Steroid Biochem; 1983 Jun; 18(6):749-57. PubMed ID: 6191128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate.
    Isaacs JT; Brendler CB; Walsh PC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):139-46. PubMed ID: 6183287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in dihydrotestosterone metabolism associated with the development of canine benign prostatic hyperplasia.
    Isaacs JT; Coffey DS
    Endocrinology; 1981 Feb; 108(2):445-53. PubMed ID: 6161001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M; Bartsch W; Thomsen M; Voigt KD
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydrotestosterone concentration of beagle prostatic tissue: effect of age and hyperplasia.
    Ewing LL; Berry SJ; Higginbottom EG
    Endocrinology; 1983 Dec; 113(6):2004-9. PubMed ID: 6196180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydrotestosterone accumulation in genital skin fibroblasts derived from elderly men with prostatic hyperplasia.
    Morimoto I; Eto S; Inoue S; Izumi M; Hara T; Saito Y; Nagataki S
    J Clin Endocrinol Metab; 1992 Aug; 75(2):632-5. PubMed ID: 1379259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of dihydrotestosterone in benign prostatic hyperplasia.
    Carson C; Rittmaster R
    Urology; 2003 Apr; 61(4 Suppl 1):2-7. PubMed ID: 12657354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aging on kinetic parameters of 3 alpha(beta)-hydroxysteroid oxidoreductases in epithelium and stroma of human normal and hyperplastic prostate.
    Tunn S; Haumann R; Hey J; Flüchter SH; Krieg M
    J Clin Endocrinol Metab; 1990 Sep; 71(3):732-9. PubMed ID: 1697599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen metabolism in the epithelial and stromal components of the human hyperplastic prostate.
    Habib FK; Tesdale AL; Chisholm GD; Busuttil A
    J Endocrinol; 1981 Oct; 91(1):23-32. PubMed ID: 6170712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate.
    Krieg M; Nass R; Tunn S
    J Clin Endocrinol Metab; 1993 Aug; 77(2):375-81. PubMed ID: 7688377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid hormones and the pathogenesis of benign prostatic hyperplasia.
    Griffiths K; Eaton CL; Harper ME; Peeling B; Davies P
    Eur Urol; 1991; 20 Suppl 1():68-77. PubMed ID: 1722166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of androgen metabolites in benign prostatic hypertrophy (BPH) and normal prostate.
    Geller J; Albert J; Lopez D; Geller S; Niwayama G
    J Clin Endocrinol Metab; 1976 Sep; 43(3):686-8. PubMed ID: 60347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative aspects of prostatic growth and androgen metabolism with aging in the dog versus the rat.
    Berry SJ; Isaacs JT
    Endocrinology; 1984 Feb; 114(2):511-20. PubMed ID: 6581042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reductive metabolism of 5 alpha-dihydrotestosterone by rat ventral and dorsolateral prostate: kinetic parameters of the enzymes.
    Lee KH; Ofner P
    J Steroid Biochem; 1988 May; 29(5):553-7. PubMed ID: 2837610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of androgens in human hyperplastic prostate: evidence for a differential localization of the enzymes involved in the metabolism.
    Abalain JH; Quemener E; Carre JL; Simon B; Amet Y; Mangin P; Floch HH
    J Steroid Biochem; 1989; 34(1-6):467-71. PubMed ID: 2483221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of new specific azasteroid inhibitors of steroid 5 alpha-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression.
    Cohen SM; Werrmann JG; Rasmusson GH; Tanaka WK; Malatesta PF; Prahalada S; Jacobs JG; Harris G; Nett TM
    Prostate; 1995 Feb; 26(2):55-71. PubMed ID: 7531846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
    Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
    J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro.
    Smith CM; Ballard SA; Wyllie MG; Masters JR
    J Steroid Biochem Mol Biol; 1994 Aug; 50(3-4):151-9. PubMed ID: 7519439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.